2-((1-Acetyl-2-methylindoline)-5-sulfonamido)-N-(4-ethylphenyl)-3-methylbutanamide

Catalog No. :
ACWCFP437
CAS No. :
1093280-46-6
Molecular Formula :
C24H31N3O4S
Molecular Weight :
457.60

IUPAC Name:2-((1-acetyl-2-methylindoline)-5-sulfonamido)-N-(4-ethylphenyl)-3-methylbutanamide

2-((1-Acetyl-2-methylindoline)-5-sulfonamido)-N-(4-ethylphenyl)-3-methylbutanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((1-Acetyl-2-methylindoline)-5-sulfonamido)-N-(4-ethylphenyl)-3-methylbutanamide
IUPAC Name2-((1-acetyl-2-methylindoline)-5-sulfonamido)-N-(4-ethylphenyl)-3-methylbutanamide
Molecular FormulaC24H31N3O4S
Molecular Weight457.60
SMILESCC(C)C(NS(=O)(C1=CC2=C(N(C(C)=O)C(C)C2)C=C1)=O)C(NC3=CC=C(CC)C=C3)=O
InChI KeyOKWHOYPLPMVZGK-UHFFFAOYSA-N
SynonymButanamide, 2-[[(1-acetyl-2,3-dihydro-2-methyl-1H-indol-5-yl)sulfonyl]amino]-N-(4-ethylphenyl)-3-methyl-
CAS No.1093280-46-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWCFP437 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZSYL725 route compound structure diagram
    ACZSYL725841275-78-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWCFP437 route product structure diagram
    ACWCFP4371093280-46-6
Inquiry

2. ACWCFP437 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWCFP437 route product structure diagram
    ACWCFP4371093280-46-6
Inquiry

Comments (0)